Raymond James Financial Services Advisors’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,343
Closed -$173K 2960
2020
Q2
$173K Buy
+10,343
New +$173K ﹤0.01% 2525
2018
Q4
Sell
-7,525
Closed -$205K 2876
2018
Q3
$205K Hold
7,525
﹤0.01% 2522
2018
Q2
$202K Sell
7,525
-177
-2% -$4.75K ﹤0.01% 2480
2018
Q1
$245K Buy
+7,702
New +$245K ﹤0.01% 2143